In support of this, our study links amplification of MDM2 and MDM4 to chromothripsis in four GBM tumors and proposes a mechanism by which the TP53 pathway could play a crucial role in creating a genomic environment favorable to chromothripsis. This evidence concerns the gene MDM2 and glioblastoma.